Advanced Clinical, a provider of clinical research solutions, has named Eman Albazzaz Executive Director of Regulatory Affairs, to lead Advanced Clinical’s regulatory and pharmacovigilance efforts.

Albazzaz is an accomplished regulatory affairs and pharmacovigilance executive with a history of successfully leading global regulatory strategy, risk-management strategy and pharmacovigilance.  Most recently she was vice president of risk management for Lundbeck (formerly Ovation Pharmaceuticals).  Prior to that, she was vice president for international regulatory affairs at Ovation.